ADVERSE REACTIONS UNDER TREATMENT BY WARFARIN (ACCORDING TO THE PHARMACOVIGILANCE DATA) AND THE POSSIBILITY OF THEIR PREVENTION BASED ON CYP2C9 CYTOCHROME GENE POLYMORPHISM INFORMATION | Zendy

AI Assistant Blog Pricing

ADVERSE REACTIONS UNDER TREATMENT BY WARFARIN (ACCORDING TO THE PHARMACOVIGILANCE DATA) AND THE POSSIBILITY OF THEIR PREVENTION BASED ON CYP2C9 CYTOCHROME GENE POLYMORPHISM INFORMATION

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.